Germany Therapeutic Drug Monitoring (TDM) Market for 28 Drugs, 2019-2023: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts

<p>This new 249-page report provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.</p><p>This report is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.</p>


 Introduction
 Worldwide Market and Technology Overview
 A. Major Therapeutic Drug Monitoring Tests
 1. Overview
 2. Carbamazepine
 3. Cyclosporin
 4. Digoxin
 5. Everolimus
 6. Gentamicin
 7. Lamotrigine/Lamictal
 8. Levetiracetam
 9. Lidocaine
 10. Lithium
 11. Phenytoin
 12. NAPA/Procainamide
 13. Quinidine
 14. Sirolimus
 15. Tacrolimus
 16. Topirimate
 17. Theophylline
 18. Valproic Acid
 B. Instrumentation Review: Operating characteristics
 and features of high-, medium-, and low-volume/POC
 analyzers manufactured by Abaxis, Abbott, Alere/Inverness,
 Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus,
 Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
 Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox,
 Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
 Table of Contents (Continued)
 C. Major In Vitro Diagnostic Technologies
 And Their Potential Applications
 1. Monoclonal and Polyclonal Antibodies
 2. Immunoassays
 a. Technological Principle
 d. Chemiluminescence
 c. Enzyme Immunoassays (EIA)
 ° Overview
 ° ELISA
 ° EMIT
 ° Electrochemical
 d. Radioimmunoassays (RIA)
 e. Immunoprecipitation
 f. Affinity Chromatography
 3. Tandem Mass Spec
 4. IT and Automation
 5. Dry Chemistry
 6. Biosensors
 
 D. Market Size, Growth and Major Supplier Shares
 Alternative Market Penetration Strategies
 A. Internal Development
 B. Collaborative Arrangements
 C. University Contracts
 D. Distribution Strategies for Decentralized
 Testing Markets
 1. Marketing Approaches
 2. Product Complexity
 3. Customer Preference
 4. Established Suppliers
 5. Emerging Suppliers
 6. Major Types of Distributors
 7. Market Segmentation

 Potential Market Entry Barriers and Risks
 A. Market Maturity
 B. Cost Containment
 C. Competition
 D. Technological Edge and Limitations
 E. Patent Protection
 F. Regulatory Constraints
 G. Decentralized Testing Market Challenges
 Competitive Assessments
 - Abbott Laboratories
 - AdnaGen/Alere
 - Agilent Technologies
 - Beckman Coulter/Danaher
 - Biomedical Diagnostics
 - BioMerieux
 - Bio-Rad
 - DiaSorin
 - Eiken
 - Fujirebio
 - Grifols
 - Instrumentation Laboratory
 - Kyowa Medex
 - Matritech/Alere
 - Ortho-Clinical Diagnostics
 - Quest Diagnostics
 - Roche
 - Siemens
 - Sysmex
 - Thermo Fisher
 - Tosoh
 - Wako
 - Wallac/PE


List Of Tables


Major Companies Developing or Marketing
TDM Tests
Major Companies Developing or Marketing
Digoxin Tests
Major Companies Developing or Marketing
Lithium Tests
Major Companies Developing or Marketing
Phenytoin Tests
Major Companies Developing or Marketing
Theophylline Tests
Major Companies Developing or Marketing
Valproic Tests
Major Companies Developing or Marketing
Biosensors for Genetic Disease Testing
Germany, Laboratories Performing TDM
Tests By Market Segment
Germany, Hospital Laboratories Performing
TDM Tests By Bed Size
Germany, Commercial/Private Laboratories
Performing TDM Tests By Annual Test Volume

Germany, TDM Test Volume Forecast By Market
Segment
Germany, Hospital Laboratories, TDM
Test Volume Forecast by Assay
Germany, Commercial/Private Laboratories,
TDM Test Volume Forecast by Assay
Germany, Physician Offices/Group
Practices, TDM Test Volume Forecast by Assay
List of Tables (continued)
Germany, TDM Reagent Market Forecast
By Market Segment

Germany, Hospital Laboratories, TDM
Reagent Market Forecast by Assay
Germany, Commercial/Private Laboratories,
TDM Reagent Market Forecast by Assay
Germany, Physician Offices/Group
Practices, TDM Reagent Market Forecast by Assay
Germany, Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares


Germany Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities

LeadingMarketResearch.coms new study is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the German hematology and flow cytometry markets during the next

USD 4500 View Report

Europe Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests:France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

This comprehensive five-country report contains 450 pages, 160 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European hematology

USD 17500 View Report

Global Biologic Therapeutic Drugs Market Report 2019, Competitive Landscape, Trends and Opportunities

The Biologic Therapeutic Drugs market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to

USD 2950 View Report

US Therapeutic Drug Monitoring (TDM) Market for 28 Drugs, 2019-2023: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts

US Therapeutic Drug Monitoring (TDM) Market for 28 Drugs, 2019-2023: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts

USD 2450 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available